361 related articles for article (PubMed ID: 29661991)
1. Information to Improve Public Perceptions of the Food and Drug Administration (FDA's) Tobacco Regulatory Role.
Osman A; Kowitt SD; Sheeran P; Jarman KL; Ranney LM; Goldstein AO
Int J Environ Res Public Health; 2018 Apr; 15(4):. PubMed ID: 29661991
[TBL] [Abstract][Full Text] [Related]
2. Public Knowledge and Credibility Perceptions of the FDA as a Tobacco Regulator.
Schmidt AM; Jarman KL; Ranney LM; Queen TL; Noar SM; Ruel L; Agans R; Hannan A; Goldstein AO
Nicotine Tob Res; 2018 Sep; 20(11):1310-1316. PubMed ID: 29059369
[TBL] [Abstract][Full Text] [Related]
3. FDA's misplaced priorities: premarket review under the Family Smoking Prevention and Tobacco Control Act.
Jenson D; Lester J; Berman ML
Tob Control; 2016 May; 25(3):246-53. PubMed ID: 27068243
[TBL] [Abstract][Full Text] [Related]
4. An evaluation of the FDA's analysis of the costs and benefits of the graphic warning label regulation.
Chaloupka FJ; Warner KE; Acemoğlu D; Gruber J; Laux F; Max W; Newhouse J; Schelling T; Sindelar J
Tob Control; 2015 Mar; 24(2):112-9. PubMed ID: 25550419
[TBL] [Abstract][Full Text] [Related]
5. Tobacco regulatory science: research to inform regulatory action at the Food and Drug Administration's Center for Tobacco Products.
Ashley DL; Backinger CL; van Bemmel DM; Neveleff DJ
Nicotine Tob Res; 2014 Aug; 16(8):1045-9. PubMed ID: 24638850
[TBL] [Abstract][Full Text] [Related]
6. Perceptions of the Food and Drug Administration as a Tobacco Regulator.
Jarman KL; Ranney LM; Baker HM; Vallejos QM; Goldstein AO
Tob Regul Sci; 2017 Apr; 3(2):239-247. PubMed ID: 29051917
[TBL] [Abstract][Full Text] [Related]
7. Beliefs about FDA tobacco regulation, modifiability of cancer risk, and tobacco product comparative harm perceptions: Findings from the HINTS-FDA 2015.
Nguyen AB; Henrie J; Slavit WI; Kaufman AR
Prev Med; 2018 May; 110():1-8. PubMed ID: 29373819
[TBL] [Abstract][Full Text] [Related]
8. FDA's expanding postmarket authority to monitor and publicize food and consumer health product risks: the need for procedural safeguards to reduce "transparency" policy harms in the post-9/11 regulatory environment.
Roller ST; Pippins RR; Ngai JW
Food Drug Law J; 2009; 64(3):577-98. PubMed ID: 19999646
[TBL] [Abstract][Full Text] [Related]
9. Research on Youth and Young Adult Tobacco Use, 2013-2018, From the Food and Drug Administration-National Institutes of Health Tobacco Centers of Regulatory Science.
Perry CL; Creamer MR; Chaffee BW; Unger JB; Sutfin EL; Kong G; Shang C; Clendennen SL; Krishnan-Sarin S; Pentz MA
Nicotine Tob Res; 2020 Jun; 22(7):1063-1076. PubMed ID: 31127298
[TBL] [Abstract][Full Text] [Related]
10. A Descriptive Longitudinal Study of Changes in Vape Shop Characteristics and Store Policies in Anticipation of the 2016 FDA Regulations of Tobacco Products, Including E-Cigarettes.
Yu S; Escobedo P; Garcia R; Cruz TB; Unger JB; Baezconde-Garbanati L; Meza L; Sussman S
Int J Environ Res Public Health; 2018 Feb; 15(2):. PubMed ID: 29439464
[TBL] [Abstract][Full Text] [Related]
11. Food and Drug Administration tobacco regulation and product judgments.
Kaufman AR; Finney Rutten LJ; Parascandola M; Blake KD; Augustson EM
Am J Prev Med; 2015 Apr; 48(4):445-51. PubMed ID: 25726094
[TBL] [Abstract][Full Text] [Related]
12. Amendments to general regulations of the Food and Drug Administration. Direct final rule.
Food and Drug Administration, HHS
Fed Regist; 2010 Nov; 75(229):73951-5. PubMed ID: 21121182
[TBL] [Abstract][Full Text] [Related]
13. Further amendments to general regulations of the Food and Drug Administration to incorporate tobacco products. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2012 Feb; 77(22):5171-6. PubMed ID: 22359802
[TBL] [Abstract][Full Text] [Related]
14. Should Graphic Warning Labels Proposed for Cigarette Packages Sold in the United States Mention the Food and Drug Administration?
Jovanova M; Skurka C; Byrne S; Kalaji M; Greiner Safi A; Porticella N; Mathios AD; Avery RJ; Dorf MC; Niederdeppe J
Nicotine Tob Res; 2021 Jan; 23(2):402-406. PubMed ID: 32770222
[TBL] [Abstract][Full Text] [Related]
15. FDA regulation of tobacco advertising and youth smoking. Historical, social, and constitutional perspectives.
Gostin LO; Arno PS; Brandt AM
JAMA; 1997 Feb; 277(5):410-8. PubMed ID: 9010174
[TBL] [Abstract][Full Text] [Related]
16. Substantial Equivalence Standards in Tobacco Governance: Statutory Clarity and Regulatory Precedent for the FSPTCA.
Carpenter D; Connolly GN; Lempert LK
J Health Polit Policy Law; 2017 Aug; 42(4):607-644. PubMed ID: 27864349
[TBL] [Abstract][Full Text] [Related]
17. Smokers' attitudes and support for e-cigarette policies and regulation in the USA.
Wackowski OA; Delnevo CD
Tob Control; 2015 Nov; 24(6):543-6. PubMed ID: 25564281
[TBL] [Abstract][Full Text] [Related]
18. Understanding the Tobacco Control Act: efforts by the US Food and Drug Administration to make tobacco-related morbidity and mortality part of the USA's past, not its future.
Husten CG; Deyton LR
Lancet; 2013 May; 381(9877):1570-80. PubMed ID: 23642698
[TBL] [Abstract][Full Text] [Related]
19. No sisyphean task: how the FDA can regulate electronic cigarettes.
Paradise J
Yale J Health Policy Law Ethics; 2013; 13(2):326-74. PubMed ID: 24340824
[TBL] [Abstract][Full Text] [Related]
20. The FDA's graphic tobacco warnings and the first amendment.
Orentlicher D
N Engl J Med; 2013 Jul; 369(3):204-6. PubMed ID: 23803137
[No Abstract] [Full Text] [Related]
[Next] [New Search]